Dec 27, 2021, 01:00 AM by User Not Found

Bio-IT World | Some of our biggest stories of the year were about the promise to limit aging through epigenetic reprogramming, new inhibitors to prevent age-associated cognitive decline, and improved single-cell sequencing technologies. Of course interest in COVID-19 remained, and we went in depth on mRNA vaccines and talked digital transformation at Pfizer and GSK in this pandemic era.

Dec 22, 2021, 01:00 AM by User Not Found

Bio-IT World | Singular Genomics launches new benchtop sequencer, collaborations in neuropsychiatry, lactation research, skin health, chronic pain, and SARS-CoV-2 vaccines, Insilico Medicine announces first-in-human trial of an AI-developed drug. Plus new products from PerkinElmer, Thermo Fisher, Genomenon, and more.

Dec 21, 2021, 09:27 AM by User Not Found

Bio-IT World | Sudeshna Das directs the data core of the Massachusetts Alzheimer’s Disease Research Center (MADRC). She recently sat down with BioTeam to discuss how MGH is collecting and working with enormous datasets to push back against Alzheimer’s.

Dec 16, 2021, 01:00 AM by User Not Found

Bio-IT World | Last week, Recursion announced two collaborations: a new collaboration with Roche and Genentech to leverage technology-enabled drug discovery through the Recursion Operating System (OS), and an expansion of an existing Bayer collaboration focused on inferential search.

Dec 15, 2021, 01:00 AM by User Not Found

Bio-IT World | A growing number of companies are endeavoring to replicate the success of gene sequencing juggernaut Illumina in the burgeoning field of proteomics. A top contender is Nautilus Biotechnology, which has spent the past few years drumming up excitement about the potential for comprehensively profiled proteins to make therapeutic and diagnostic development more effective and time efficient.

Dec 14, 2021, 01:00 AM by User Not Found

Bio-IT World | Seven Bridges Genomics has launched a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies. The UPN will combine de-identified sequencing data and EHR content for five million patients and allow biopharma companies to license cohorts from that dataset for research. Licensing fees from biopharma will fund the network.

Dec 10, 2021, 01:00 AM by User Not Found

Bio-IT World | The demand for proteomics studies has increased in recent years, with growing emphasis on datasets capturing vast amounts of proteomics data from large cohorts of patients, with thousands of proteins measured in each person. In part, this has been led by developments in computational methods, like deep learning to analyze data, as well as advancements in sample analytical methodologies.

Dec 9, 2021, 01:00 AM by User Not Found

Bio-IT World | A group of cell engineers and synthetic biologists at Harvard University and Massachusetts Institute of Technology (MIT) has developed a tech tool called “eToeholds” that could help improve the safety and efficacy of RNA and cell therapies, in addition to enabling new forms of detection.

Dec 8, 2021, 09:14 AM by User Not Found

Bio-IT World | The ultimate challenge of drug delivery—successfully getting a medicine into a cell—has several lines of pursuit when it comes to nucleic acid-based vaccines and the latest and greatest is an ancient cupping technique which, at least in rodents, is almost unfathomably good at driving immune responses. To say the Rutgers University research team was surprised by the finding would be an understatement.

Dec 6, 2021, 16:50 PM by

Dec 6, 2021, 16:50 PM by

Research will focus on CUH’s areas of disease expertise and specialism in cancer, cardiovascular disease and rare diseases New agreement covers 3 million patient records and brings the combined total of de-identified patient data directly accessible for medical research to 25.5 million patients

Dec 6, 2021, 16:50 PM by

Dec 3, 2021, 01:00 AM by User Not Found

Bio-IT World | At Oxford Nanopore’s virtual Community Meeting this week, CTO Clive Brown presented new chemistries, previewed the Apple iPad Pro-powered Mk1D with an integrated MinION, teased the diagnostic capacities of “outy” sequencing, unveiled a browser base caller, and more.

Dec 2, 2021, 01:00 AM by User Not Found

Bio-IT World | Platforms for machine-learning generative biology and cloud R&D, drug delivery chip for therapies at the tumor site, and AI-driven drug discovery and robotics.

Dec 1, 2021, 15:29 PM by

Vyasa announced that it has joined the NVIDIA Partner Network (NPN) as a Solution Advisor (SA) – Consultant partner. Inclusion in the program enhances the availability of Vyasa’s deep learning applications to NVIDIA’s customers and partners.

Dec 1, 2021, 15:17 PM by

CPhI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

Dec 1, 2021, 15:17 PM by

Qlucore is delighted to announce a joint project with Heidelberg University Hospital to develop Qlucore Diagnostics - a medical device artificial intelligence (AI) powered software for improved clinical diagnostics of lung cancer.

Dec 1, 2021, 15:17 PM by

Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study

Dec 1, 2021, 15:17 PM by

Caption Health is announcing that Joe DeVivo, President of Hospitals and Health Systems at Teladoc Health, is joining its board of directors. Mr. DeVivo will share his expertise in Med Tech and Health Tech, gleaned over decades in the industry, to help guide the company on its mission to democratize access to high-quality ultrasounds.

Dec 1, 2021, 15:17 PM by

RefleXion Medical, Inc., has been granted FDA Breakthrough Device Designation for its biology-guided radiotherapy (BgRT) for use in treating lung tumors. The breakthrough potential of BgRT lies in its ability to detect and then immediately treat multiple moving tumors. It is the first and only technology to use injected radiotracers to produce active signals, called emissions, from each tumor to guide treatment delivery.